Orchid Pharma Financials
NSE: ORCHPHARMA | BSE: 524372
₹1,018.45
₹-6.40
(-0.62%)
As on 10-Sep-2026 15:19IST
Market cap
₹6,085 Cr
Revenue (TTM)
₹943 Cr
P/E Ratio
702.1
P/B Ratio
4.7
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
942.57
|
921.93
|
819.37
|
665.90
|
559.56
|
450.06
|
|
|
|
|
|
|
Total Income
|
968.12
|
956.37
|
850.50
|
685.33
|
568.56
|
465.27
|
|
|
|
|
|
|
Total Expenditure
|
901.62
|
811.33
|
708.58
|
581.60
|
504.98
|
399.40
|
|
|
|
|
|
|
EBITDA
|
40.95
|
110.60
|
110.79
|
84.30
|
54.58
|
50.66
|
|
|
|
|
|
|
Depreciation
|
37.75
|
34.55
|
33.24
|
54.79
|
87.02
|
108.92
|
|
|
|
|
|
|
EBIT
|
3.21
|
76.05
|
77.55
|
29.51
|
-32.45
|
-58.25
|
|
|
|
|
|
|
Interest
|
12.23
|
14.93
|
16.74
|
32.90
|
33.46
|
52.21
|
|
|
|
|
|
|
Other Income
|
25.55
|
34.45
|
31.13
|
19.43
|
9.00
|
15.21
|
|
|
|
|
|
|
Exceptional Items
|
-6.57
|
--
|
--
|
39.21
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
9.96
|
95.56
|
91.95
|
55.25
|
-56.90
|
-95.25
|
|
|
|
|
|
|
Provision for Tax
|
0.07
|
-0.19
|
-3.12
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit after Tax
|
9.88
|
95.76
|
95.06
|
55.25
|
-56.90
|
-95.25
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
-1.21
|
3.90
|
-2.90
|
-2.15
|
-3.52
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
8.67
|
99.66
|
92.17
|
46.32
|
-1.95
|
-116.53
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,287.79
|
1,267.29
|
1,169.47
|
688.65
|
647.38
|
652.91
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
344.16
|
134.96
|
124.43
|
164.67
|
222.40
|
442.26
|
|
|
|
|
|
|
Current Liabilities
|
278.97
|
285.57
|
259.97
|
371.89
|
240.78
|
142.08
|
|
|
|
|
|
|
Total Liabilities
|
1,910.91
|
1,687.91
|
1,553.87
|
1,225.21
|
1,110.56
|
1,237.25
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,080.13
|
880.50
|
763.12
|
724.20
|
712.91
|
687.40
|
|
|
|
|
|
|
Current Assets
|
683.90
|
807.32
|
790.75
|
501.01
|
384.36
|
429.01
|
|
|
|
|
|
|
Total Assets
|
1,910.91
|
1,687.91
|
1,553.87
|
1,225.21
|
1,110.56
|
1,237.25
|
|
|
|
|
|
|
Total Debt*
|
--
|
174.24
|
134.48
|
331.35
|
267.95
|
452.74
|
|
|
|
|
|
|
Net Current Assets
|
404.93
|
521.75
|
530.78
|
129.12
|
143.58
|
286.92
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
14.10
|
56.97
|
42.48
|
42.88
|
45.12
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
19.22
|
125.99
|
18.34
|
92.47
|
23.59
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-26.93
|
-312.03
|
-31.21
|
112.94
|
67.21
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
25.22
|
167.04
|
31.17
|
-216.80
|
-164.99
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
17.51
|
-19.00
|
18.29
|
-11.39
|
-74.20
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
3.05
|
19.65
|
18.17
|
11.35
|
-0.48
|
-28.55
|
|
|
|
|
|
|
Cash EPS (₹)
|
1.45
|
25.69
|
25.30
|
26.96
|
7.38
|
3.35
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
217.00
|
249.86
|
230.58
|
168.72
|
158.61
|
159.96
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
3.79
|
24.84
|
4.49
|
22.66
|
5.78
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-25.30
|
10.97
|
-13.22
|
18.45
|
-4.00
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
8.05
|
9.35
|
9.11
|
-2.32
|
-3.53
|
|
|
|
|
|
|
ROE (%)
|
1.21
|
7.86
|
10.23
|
8.27
|
-8.75
|
-13.43
|
|
|
|
|
|
|
ROA (%)
|
0.55
|
5.91
|
6.84
|
4.73
|
-4.85
|
-7.06
|
|
|
|
|
|
|
EBIT Margin (%)
|
0.34
|
8.25
|
9.46
|
4.43
|
-5.80
|
-12.94
|
|
|
|
|
|
|
Net Margin (%)
|
1.02
|
10.01
|
11.18
|
8.06
|
-10.01
|
-20.47
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
14.13
|
15.66
|
16.52
|
5.38
|
3.04
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.20
|
12.52
|
23.05
|
19.00
|
24.33
|
-6.97
|
|
|
|
|
|
|
EBIT Growth (%)
|
-92.44
|
-1.93
|
162.82
|
190.95
|
44.30
|
33.61
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-76.03
|
0.73
|
72.07
|
197.10
|
40.26
|
-36.67
|
|
|
|
|
|
|
EPS Growth (%)
|
-87.52
|
8.13
|
60.13
|
2,474.06
|
98.33
|
11.09
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
8.36
|
69.82
|
6.37
|
-0.85
|
-14.76
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
702.13
|
39.54
|
57.52
|
33.87
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
4.68
|
3.11
|
4.53
|
2.28
|
1.79
|
15.41
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
95.61
|
27.13
|
36.42
|
18.03
|
22.34
|
159.31
|
|
|
|
|
|
|
Close Price (₹)
|
972.80
|
776.10
|
1,044.85
|
383.25
|
285.20
|
2,407.55
|
|
|
|
|
|
|
High Price (₹)
|
1,096.40
|
1,998.00
|
1,359.95
|
438.50
|
2,680.00
|
2,465.15
|
|
|
|
|
|
|
Low Price (₹)
|
471.30
|
761.10
|
371.20
|
268.15
|
260.20
|
18.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
6,084.64
|
3,940.40
|
5,301.15
|
1,568.99
|
1,160.41
|
10,061.87
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.25
|
0.14
|
0.12
|
0.48
|
0.41
|
0.69
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.03
|
0.01
|
0.20
|
0.04
|
0.00
|
|
|
|
|
|
|
Current Ratio
|
2.45
|
2.83
|
3.04
|
1.35
|
1.60
|
3.02
|
|
|
|
|
|
|
Quick Ratio
|
1.53
|
1.68
|
2.03
|
0.73
|
0.88
|
1.94
|
|
|
|
|
|
|
Interest Coverage
|
1.81
|
7.40
|
6.49
|
2.68
|
-0.70
|
-0.82
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
27.99
|
26.23
|
23.87
|
32.32
|
30.48
|
30.15
|
|
|
|
|
|
|
Asset Turnover
|
0.52
|
0.57
|
0.59
|
0.57
|
0.48
|
0.33
|
|
|
|
|
|
|
Receivable days
|
--
|
86.58
|
91.49
|
105.72
|
99.89
|
82.59
|
|
|
|
|
|
|
Inventory Days
|
--
|
116.91
|
109.80
|
110.01
|
106.18
|
119.45
|
|
|
|
|
|
|
Payable days
|
--
|
151.46
|
152.17
|
162.30
|
161.59
|
168.95
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
52.03
|
49.12
|
53.43
|
44.47
|
33.09
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
